Abstract
Background/aimsGlucagon-like peptide-1 receptor (GLP-1R) agonists regulate blood glucose and are commonly used to treat type 2 diabetes mellitus. Recent work showed that treatment with the GLP-1R agonist NLY01 decreased retinal...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have